Xia Dong, He Hong-Yuan, Xu Liang, Quan Yi, Zuo Huai-Quan, Yan Lu-Nan, Li Bo, Zeng Yong, Pan Guang-Dong
Department of General Surgery, Affiliated Hospital of Luzhou Medical College, Luzhou 646000, Sichuan Province, China.
World J Gastroenterol. 2008 Dec 21;14(47):7264-6. doi: 10.3748/wjg.14.7264.
The safety and feasibility of pregnancy following liver transplantation (LT) have been accredited in a series of LT center. The first case in mainland China is reported. The follow-up data of a 22-year-old pregnant patient with end-stage liver disease undergone orthotopic liver transplantation were analyzed retrospectively. After surgery, the patient was uneventfully recovered and became pregnant 33 mo after LT. The patient was closely monitored and treated with a standard and individualized triple-drug immunosuppressive therapy throughout her pregnancy. Caesarean section was performed in March 18, 2004, and a health live-born infant was delivered. After the delivery, a 4-year follow-up period indicated that the patient was satisfactory with her condition and her baby was healthy. Our case shows that a successful pregnancy following LT is possible and safe in women with end-stage liver diseases under close monitoring. Three factors including mother, baby, and transplanted liver function must be considered for the safety of high-risk pregnancies.
肝移植(LT)后妊娠的安全性和可行性已在一系列肝移植中心得到认可。本文报道了中国大陆的首例病例。对一名接受原位肝移植的终末期肝病22岁孕妇的随访数据进行回顾性分析。术后患者恢复顺利,肝移植后33个月怀孕。整个孕期对患者进行密切监测,并采用标准且个体化的三联药物免疫抑制治疗。2004年3月18日行剖宫产术,分娩出一名健康的活婴。分娩后4年的随访表明,患者对自身状况满意,婴儿健康。我们的病例表明,在密切监测下,终末期肝病女性肝移植后成功妊娠是可能且安全的。为确保高危妊娠的安全,必须考虑母亲、婴儿和移植肝功能这三个因素。